This activity is designed to help urology advanced practice providers and nurses understand best practice approaches for identifying metastatic hormone-sensitive prostate cancer to ensure optimal patient outcomes…
Advanced prostate cancer treatments continue to evolve with new treatments in the M0CRPC, such as daralutamide and apalutamide, precision treatments based on genetic testing including PARP inhibitors and PD1 immunotherapy…
Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.